Drug Metabolism and Personalized Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population
Journal Name: Drug Metabolism and Personalized Therapy Issue: Ahead of print (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 23, 2017 Category: Drugs & Pharmacology Source Type: research
Role of treatment-modifying MTHFR677C > T and 1298A > C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy
Journal Name: Drug Metabolism and Personalized Therapy Issue: Ahead of print (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 23, 2017 Category: Drugs & Pharmacology Source Type: research
Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population
Journal Name: Drug Metabolism and Personalized Therapy Volume: 32 Issue: 1 Pages: 39-47 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 22, 2017 Category: Drugs & Pharmacology Source Type: research
Role of treatment-modifying MTHFR677C > T and 1298A > C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy
Journal Name: Drug Metabolism and Personalized Therapy Volume: 32 Issue: 1 Pages: 23-32 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 22, 2017 Category: Drugs & Pharmacology Source Type: research
Genotyping CYP2D6 by three different methods: advantages and disadvantages
Journal Name: Drug Metabolism and Personalized Therapy Issue: Ahead of print (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 16, 2017 Category: Drugs & Pharmacology Source Type: research
Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population
Journal Name: Drug Metabolism and Personalized Therapy Issue: Ahead of print (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 16, 2017 Category: Drugs & Pharmacology Source Type: research
Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population
Journal Name: Drug Metabolism and Personalized Therapy Volume: 32 Issue: 1 Pages: 11-21 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 10, 2017 Category: Drugs & Pharmacology Source Type: research
Genotyping CYP2D6 by three different methods: advantages and disadvantages
Journal Name: Drug Metabolism and Personalized Therapy Volume: 32 Issue: 1 Pages: 33-37 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - February 6, 2017 Category: Drugs & Pharmacology Source Type: research
Pharmacogenetic studies: a tool to improve antidepressant therapy
Journal Name: Drug Metabolism and Personalized Therapy Volume: 31 Issue: 4 Pages: 197-204 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - November 27, 2016 Category: Drugs & Pharmacology Source Type: research
The Santorini Conferences continue
Journal Name: Drug Metabolism and Personalized Therapy Volume: 31 Issue: 4 Pages: 179-179 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - November 27, 2016 Category: Drugs & Pharmacology Source Type: research
Frontmatter
Journal Name: Drug Metabolism and Personalized Therapy Volume: 31 Issue: 4 Pages: i-iii (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - November 27, 2016 Category: Drugs & Pharmacology Source Type: research
Acknowledgment
Journal Name: Drug Metabolism and Personalized Therapy Volume: 31 Issue: 4 Pages: 239-239 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - November 23, 2016 Category: Drugs & Pharmacology Source Type: research
Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition
Journal Name: Drug Metabolism and Personalized Therapy Volume: 31 Issue: 4 Pages: 229-234 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - November 21, 2016 Category: Drugs & Pharmacology Source Type: research
1846G > A polymorphism of CYP2D6 gene and extrapyramidal side effects during antipsychotic therapy among Russians and Tatars: a pilot study
Journal Name: Drug Metabolism and Personalized Therapy Volume: 31 Issue: 4 Pages: 205-212 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - November 21, 2016 Category: Drugs & Pharmacology Source Type: research
CYP2D6 variability in populations from Venezuela
Journal Name: Drug Metabolism and Personalized Therapy Volume: 31 Issue: 4 Pages: 181-189 (Source: Drug Metabolism and Personalized Therapy)
Source: Drug Metabolism and Personalized Therapy - November 21, 2016 Category: Drugs & Pharmacology Source Type: research
